Live Chat

Blacktrace acquired Centeo Biosciences

Centeo-logo-v2Blacktrace Holdings has acquired Centeo Biosciences, a leading provider of sample preparation products for life-sciences.

Centeo was formed in 2003 with the aim to develop products for crystallization applications and give scientists better control of key crystallization parameters. The core principles were to develop out of the box intuitive, portable products which add value to the science through understanding the practical issues around crystallization. Centeo’s first product range included an intuitive portable incubator with highly accurate temperature control of individual microwells.

Blacktrace Group CEO, Mark Gilligan, said: “Centeo’s products provide an elegant solution to a real problem in the life and physical sciences of accurately controlling temperature within the micro-well and micro-vial environment and we are delighted to be taking the technology global.”